Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
Bally AG: El proyecto DOT (B)
Sabrià, Frederic; Moscoso, PhilipCaso P-1054Servicios y operacionesTras el análisis de los problemas planteados en el caso A, se presentan diversas alternativas de solución.Desde 5,74 €
-
Bally AG: El proyecto DOT (A)
Sabrià, Frederic; Moscoso, PhilipCaso P-1053Servicios y operacionesEl caso describe la situación de una de las empresas líderes del mercado de artículos de lujo. Su vicepresidente ejecutivo se plantea modificaciones en su cadena de suministro para aumentar la agilidad.Desde 8,20 €
-
Bally AG: The DOT project (B)
Sabrià, Frederic; Moscoso, PhilipCaso P-1054-EServicios y operacionesAfter analyzing the problems described in case A, case B presents various possible solutions.Desde 5,74 €
-
Bally AG: The DOT project (A)
Sabrià, Frederic; Moscoso, PhilipCaso P-1053-EServicios y operacionesThe case describes the situation of one of the leading companies in the luxury goods market. The company's executive vice-president is planning some changes in the supply chain to enhance the speed of response.Desde 8,20 €
-
Habitat for Humanity International in South Africa, Teaching Note
Segel, Arthur I; Retsinas, Nicolas P.Nota del Instructor HBS-207014-EFinanzasTeaching Note to (207-016).Desde 0,00 €
-
Netflix (Spanish version)
Shih, Willy; Kaufman, Stephen P.; Spinola, DavidCaso HBS-608S26Dirección estratégicavideo-on-demand. How should Netflix respond?Desde 8,20 €
-
Nestl : Nutrition, Health, and Wellness
Bell, David E.; McLoughlin, Damien P.; Kindred, NatalieCaso HBS-517052-EMarketingDesde 8,20 €
-
Innovation and Growth at Actelion Ltd.
Pisano, Gary P.; Beyersdorfer, Daniela; Dittrich, RuthCaso HBS-611065-ELiderazgo y Dirección de personasIn late 2010, Jean-Paul Clozel, CEO of the Swiss biotech pharmaceuticals firm Actelion, looks back on a successful decade. The small venture that he had started with a few of his scientist colleagues in the late 1990s to discover novel medicine in a research-driven organisation had grown into one of Europe's largest biotech firms by revenues. Their success was mainly founded on their orphan indication drug Tracleer, which Actelion sold and market...Desde 8,20 €
-
The De Beers Group: Exploring the Diamond Reselling Opportunity, Teaching Note
Esty, Benjamin C.; Gross, Daniel P.; Pickle, Lauren G.Nota del Instructor HBS-717481-EDirección estratégicaTeaching note for case 717430.Desde 0,00 €
-
The De Beers Group: Exploring the Diamond Reselling Opportunity
Esty, Benjamin C.; Gross, Daniel P.; Pickle, Lauren G.Caso HBS-717430-EDirección estratégicaIn September 2014, Tom Montgomery (SVP of strategic initiatives at the De Beers Group) and his team launched a pilot program in the United States to explore the $1 billion diamond market for pre-owned (recycled) diamonds. According to Montgomery, the motivation for the pilot program was to improve the consumer reselling experience and to enhance "diamond equity". Somewhat paradoxically, consumers typically received very low prices when they tried...Desde 8,20 €